GSK’s Jideytro Shows 94% Response in ROS1 Lung Cancer
London, United Kingdom, September 13, 2026 GSK has announced positive registrational data from the Phase I/II ARROS-1 trial supporting...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
London, United Kingdom, September 13, 2026 GSK has announced positive registrational data from the Phase I/II ARROS-1 trial supporting...
Basel, Switzerland, September 13, 2026 Roche announced that its collaborator MediLink Therapeutics has reported positive Phase III clinical trial...
Paris, France and New York, USA, September 14, 2026 Cyllene Therapeutics announced that the U.S. Food and Drug Administration...
Osaka, Japan & Cambridge, Massachusetts, U.S., September 14, 2026 Takeda has announced that the U.S. Food and Drug Administration...
Seoul, South Korea, September 14, 2026 AstraZeneca and Daiichi Sankyo announced positive results from the Phase III DESTINY-Lung04 trial,...
Wilmington, Delaware, U.S., September 14, 2026 AstraZeneca announced updated results from the Phase III ADAURA trial, showing sustained long-term...
Taipei, Taiwan, September 11, 2026 Avance Clinical has received the Australia-Taiwan Business Excellence Award from the Australia New Zealand...
Burlington, North Carolina, USA, September 8, 2026 Labcorp has acquired MLM Medical Labs, strengthening its global central laboratory and...
BOSTON — September 8, 2026 Avalyn Pharma presented new data at the European Respiratory Society (ERS) International Congress 2026...
SAN ANTONIO — September 8, 2026 PT Prodia Diacro Laboratories (Prodia the CRO) has received Frost & Sullivan’s 2026...
